Analysts Viewpoint
Prime Medicine Inc (PRME) receives a Neutral rating from Citigroup
Prime Medicine Inc’s filing revealed that its 10% Owner Liu David R. acquired Company’s shares for reported $52830.0 on Jun
Menu
Prime Medicine Inc’s filing revealed that its 10% Owner Liu David R. acquired Company’s shares for reported $52830.0 on Jun
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Prime Medicine Inc’s recent filing unveils that its 10% Owner Liu David R. acquired Company’s shares for reported $52830.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Prime Medicine
Prime Medicine Inc’s recent filing unveils that its 10% Owner Liu David R. acquired Company’s shares for reported $45402.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Prime Medicine
Prime Medicine Inc’s filing revealed that its 10% Owner Liu David R. acquired Company’s shares for reported $45402.0 on Jun
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Prime Medicine